# Andrew K. Godwin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrew-k-godwin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,880 |
| Field | BRCA gene mutations in cancer |
| h-index | 114 |
| i10-index | 413 |
| Last Known Institution | University of Kansas |
| OpenAlex ID | https://openalex.org/A5033625395 |
| ORCID iD | https://orcid.org/0000-0002-3987-9580 |
| Works | 994 |

## Researcher papers

- [Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)](https://scholariq.org/papers/pathology-of-breast-and-ovarian-cancers-among-i-brca1-i-and-i-brca2-i-mutation/)
- [A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations](https://scholariq.org/papers/a-pan-cancer-proteogenomic-atlas-of-pi3k-akt-mtor-pathway-alterations/)
- [Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses](https://scholariq.org/papers/genome-wide-association-study-identifies-32-novel-breast-cancer-susceptibility/)
- [Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer](https://scholariq.org/papers/association-of-type-and-location-of-i-brca1-i-and-i-brca2-i-mutations-with-risk/)
- [Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk](https://scholariq.org/papers/genome-wide-association-study-in-brca1-mutation-carriers-identifies-novel-loci/)
- [A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24](https://scholariq.org/papers/a-genome-wide-association-study-identifies-susceptibility-loci-for-ovarian/)
- [w4200350191](https://scholariq.org/papers/w4200350191/)
- [Identification of six new susceptibility loci for invasive epithelial ovarian cancer](https://scholariq.org/papers/identification-of-six-new-susceptibility-loci-for-invasive-epithelial-ovarian/)
- [Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer](https://scholariq.org/papers/interplay-between-brca1-and-rhamm-regulates-epithelial-apicobasal-polarization/)
- [Prediction of Breast and Prostate Cancer Risks in Male <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Using Polygenic Risk Scores](https://scholariq.org/papers/prediction-of-breast-and-prostate-cancer-risks-in-male-i-brca1-i-and-i-brca2-i/)
- [Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer](https://scholariq.org/papers/clinical-and-biomarker-findings-of-neoadjuvant-pembrolizumab-and-carboplatin/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [University of Kansas](https://scholariq.org/institutions/university-of-kansas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.